Pamukkale University
pau.edu.trTotal trials
303
Active
42
Phase 3
0
Total enrollment
25,737
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Fluticasone propionate nasal spray | — | — | — | — | — | 1 | |
| Fluticasone propionate-azelastine nasal spray | — | — | — | — | — | 1 | |
| Autologous Platelet-Rich Plasma | — | — | — | — | — | 1 | |
| Conditioned serum | — | — | — | — | — | 1 | |
| intracochlear platelet rich fibrin administration | — | — | — | — | — | 1 |
Next readouts
- 2023-10-30
- 2025-12-01
- 2026-06-30
Top conditions
- Stroke10
- Pain6
- Multiple Sclerosis6
- Urinary Bladder, Overactive6
- Hand Injuries5
- Cerebral Palsy5
- Elderly4
- Flexibility4
Frequently asked questions about Pamukkale University
- How many clinical trials does Pamukkale University have on ClinicalTrials.gov?
- Pamukkale University is listed as the lead sponsor on 303 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Pamukkale University's trials are in Phase 3?
- 0 of Pamukkale University's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Pamukkale University focus on?
- Pamukkale University's most-studied conditions on ClinicalTrials.gov are Stroke, Pain, Multiple Sclerosis, Urinary Bladder, Overactive, Hand Injuries.
- When are Pamukkale University's next clinical trial readouts?
- Pamukkale University has 3 upcoming primary-completion readouts tracked here; the soonest is “INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION”, expected around 2023-10-30.